Daniel P. O'Day
2020
In 2020, Daniel P. O'Day earned a total compensation of $19M as Chairman and Chief Executive Officer at Gilead Sciences, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $4,713,390 |
|---|---|
| Option Awards | $3,125,041 |
| Salary | $1,702,885 |
| Stock Awards | $8,388,056 |
| Other | $1,068,723 |
| Total | $18,998,095 |
O'Day received $8.4M in stock awards, accounting for 44% of the total pay in 2020.
O'Day also received $4.7M in non-equity incentive plan, $3.1M in option awards, $1.7M in salary and $1.1M in other compensation.
Rankings
In 2020, Daniel P. O'Day's compensation ranked 249th out of 13,090 executives tracked by ExecPay. In other words, O'Day earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 249 out of 13,090 | 98th |
Division Manufacturing | 74 out of 5,617 | 99th |
Major group Chemicals And Allied Products | 20 out of 2,248 | 99th |
Industry group Drugs | 19 out of 1,948 | 99th |
Industry Biological Products, Except Diagnostic Substances | 8 out of 411 | 98th |
Pay ratio
| Daniel P. O'Day's Pay | $18,998,095 |
|---|---|
| Median Employee's Pay | $250,190 |
| Pay Ratio | 76to 1 |
In 2020, the annual total compensation of Daniel P. O'Day was $18,998,095.
The annual total compensation of the median employee at Gilead Sciences was $250,190.
The ratio of Daniel P. O'Day's pay to the pay of median employee was therefore 76 to one.
Source: SEC filing on March 30, 2021.
O'Day's colleagues
We found four more compensation records of executives who worked with Daniel P. O'Day at Gilead Sciences in 2020.